About alverine citrate
|Type of medicine||Antispasmodic|
|Used for||Pain caused by gastro-intestinal muscle cramps
Period pain cramps
|Also called||Spasmonal®, Spasmonal® Forte
Audmonal®, Audmonal® Forte
Alverine citrate is an antispasmodic medicine which is used to relieve abdominal muscle spasms. It is particularly useful to help ease the spasm-type pain that may be associated with irritable bowel syndrome and similar conditions. It can also be used to help relieve period pain cramps.
Alverine citrate works by relaxing the muscles causing the problem.
Before taking alverine citrate
Before taking alverine citrate make sure your doctor or pharmacist knows:
- If you are pregnant or breast-feeding.
- If you know you have a condition called paralytic ileus (a blockage of the bowel).
- If you are taking other medicines, including those available to buy without a prescription, herbal and complementary medicines.
- If you have ever had an allergic reaction to this or to any other medicine.
How to take alverine citrate
- Before starting this treatment, read the manufacturer's printed information leaflet from inside the pack. The leaflet will give you more information about the specific brand and strength of capsule you have been given, and any possible side-effects from taking it.
- Take alverine citrate exactly as your doctor or pharmacist has told you. The usual dose is one capsule which can be taken one to three times a day.
- You can take the capsules before or after meals.
- If you forget to take a dose, do not worry, just take the next dose as normal. Do not take two doses together to make up for a forgotten dose.
Getting the most from your treatment
- Alverine citrate can be purchased from pharmacies by people who have previously been diagnosed by a doctor. If this is the first time you have had these symptoms, you should consult your doctor before using any treatment.
- If you develop any new symptoms, or if your symptoms worsen, or if your symptoms have not improved within two weeks of taking these capsules, you should see your doctor for advice.
- If you buy any other medicines, check with a pharmacist that they are safe to take with this medicine.
Can alverine citrate cause problems?
Along with their useful effects, most medicines can cause unwanted side-effects although not everyone experiences them. These usually improve as your body adjusts to the new medicine, but speak with your doctor or pharmacist if any of the following side-effects continue or become troublesome.
|Possible alverine citrate side-effects||What can I do if I experience this?|
|Feeling sick||Stick to simple foods|
|Headache||Ask your pharmacist to recommend a suitable painkiller|
|Feeling dizzy||If this happens, do not drive or use tools or machines|
|Itching and skin rash||Use a moisturiser to help soothe your skin. Speak with your doctor or pharmacist if this continues|
If you experience any other symptoms which you think may be due to this medicine, speak with your doctor or pharmacist.
How to store alverine citrate
- Keep all medicines out of the reach and sight of children.
- Store in a cool, dry place, away from direct heat and light.
Important information about all medicines
Further reading & references
- British National Formulary; 62nd Edition (Sep 2011) British Medical Association and Royal Pharmaceutical Society of Great Britain, London
- Manufacturer's PIL, Spasmonal® 60 mg; Manufacturer's PIL, Spasmonal® 60 mg, Meda Pharmaceuticals, electronic Medicines Compendium. Dated November 2011.
- Manufacturer's PIL, Spasmonal® Forte 120 mg hard capsules; Manufacturer's PIL, Spasmonal® Forte 120 mg hard capsules, Meda Pharmaceuticals, electronic Medicines Compendium. Dated November 2011.
Disclaimer: This article is for information only and should not be used for the diagnosis or treatment of medical conditions. EMIS has used all reasonable care in compiling the information but make no warranty as to its accuracy. Consult a doctor or other health care professional for diagnosis and treatment of medical conditions. For details see our conditions.
|Original Author: Helen Allen||Current Version: Helen Allen||Peer Reviewer: Prof Cathy Jackson|
|Last Checked: 19/01/2012||Document ID: 3806 Version: 24||© EMIS|
The authors and editors of this article create up to date content reflecting reliable research evidence, guidance and best clinical practice. Learn more